PockLigGPT: Pocket-Sequence-Conditioned Molecular Generation with GPTs and RL

Formulates ligand design as a sequence-generation problem conditioned on the amino acid composition of the protein pocket, rather than producing fixed 3D coordinates. Relative to 3D structure-based generative methods that explicitly model pocket-ligand geometry, it offers a complementary sequence-based route that uses pocket amino acid sequences as the conditioning signal. Supported by the method description and docking-oriented results under a standardized evaluation protocol; the abstract does not report specific values.

Proposes a four-stage training pipeline: large-scale ZINC20 chemical pretraining, ChEMBL bioactivity-oriented adaptation, pocket-sequence-conditioned fine-tuning, and pocket-specific docking-guided reinforcement learning with AutoDock Vina-based rewards. Integrates multistage training and docking-guided reinforcement learning into a practical generation pipeline, addressing whether sequence-based pocket information can guide generation, whether multistage training improves pocket-specific generation, and whether docking-guided reinforcement learning can be integrated into practice. Evidence comes from the paper's explicit description of the training stages and reward source, together with reported performance under a standardized evaluation protocol.

Achieves competitive docking-oriented performance while maintaining chemical plausibility and drug-likeness. Reports chemical plausibility and Lipinski-based drug-likeness alongside docking-oriented metrics, responding to the concern that 3D generative outputs are not always chemically realistic or practically usable. Based on docking-oriented results under a standardized evaluation protocol and reported chemical plausibility, physicochemical profiles, and Lipinski-based drug-likeness.

Docking studies on Alzheimer's disease-associated targets and token-level analyses support its utility for de novo drug design. Extends evaluation from general benchmarks to specific disease-associated targets and adds token-level analysis to inspect model behavior. Evidence consists of docking results on Alzheimer's disease-associated targets and token-level analyses; the abstract provides no sample sizes or specific statistics.

The work targets de novo ligand generation conditioned on protein pocket amino acid sequences and evaluated through docking-oriented criteria, suited to researchers and early design pipelines that want candidate molecules without directly outputting 3D coordinates; its conclusions rest on a standardized evaluation protocol, docking studies on Alzheimer's disease-associated targets, and token-level analyses, so the scope of applicability corresponds to those evaluation settings.

A careful reader would still watch how consistently sequence-based pocket conditioning performs across different target families; how the balance between docking-guided reinforcement learning rewards and chemical plausibility or drug-likeness shifts as training proceeds; the specific settings and scale of the Alzheimer's disease-associated target docking studies and token-level analyses; and comparability with 3D structure-based methods under the standardized evaluation protocol. Because this reading is at the abstract level, figures and specific values are not included, and these questions are open points to keep in mind when reading the full text.